MDT

98.48

+2.27%↑

A

145.89

-0.98%↓

VEEV

220.79

-1.04%↓

HQY

87.08

+0.99%↑

PHR.US

16.37

+0.49%↑

MDT

98.48

+2.27%↑

A

145.89

-0.98%↓

VEEV

220.79

-1.04%↓

HQY

87.08

+0.99%↑

PHR.US

16.37

+0.49%↑

MDT

98.48

+2.27%↑

A

145.89

-0.98%↓

VEEV

220.79

-1.04%↓

HQY

87.08

+0.99%↑

PHR.US

16.37

+0.49%↑

MDT

98.48

+2.27%↑

A

145.89

-0.98%↓

VEEV

220.79

-1.04%↓

HQY

87.08

+0.99%↑

PHR.US

16.37

+0.49%↑

MDT

98.48

+2.27%↑

A

145.89

-0.98%↓

VEEV

220.79

-1.04%↓

HQY

87.08

+0.99%↑

PHR.US

16.37

+0.49%↑

Search

Mersana Therapeutics Inc

Gesloten

SectorGezondheidszorg

28.46

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.46

Max

28.46

Belangrijke statistieken

By Trading Economics

Inkomsten

17M

-7.5M

Verkoop

8M

11M

EPS

-1.51

Winstmarge

-68.535

Werknemers

102

EBITDA

16M

-7.1M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+5.74% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

102M

145M

Vorige openingsprijs

28.46

Vorige sluitingsprijs

28.46

Nieuwssentiment

By Acuity

50%

50%

190 / 372 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Mersana Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 jan 2026, 23:08 UTC

Acquisities, Fusies, Overnames

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 jan 2026, 21:39 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 jan 2026, 20:54 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks -- Update

8 jan 2026, 20:44 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Restart Merger Talks

8 jan 2026, 17:05 UTC

Acquisities, Fusies, Overnames

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 jan 2026, 16:43 UTC

Belangrijke Marktbewegers

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 jan 2026, 23:44 UTC

Marktinformatie

Nikkei May Rise on Weaker Yen -- Market Talk

8 jan 2026, 23:37 UTC

Marktinformatie

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 jan 2026, 22:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 jan 2026, 22:42 UTC

Marktinformatie

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 jan 2026, 22:30 UTC

Acquisities, Fusies, Overnames

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 jan 2026, 21:53 UTC

Winsten

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

8 jan 2026, 21:10 UTC

Acquisities, Fusies, Overnames

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 jan 2026, 21:09 UTC

Marktinformatie

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 jan 2026, 21:09 UTC

Acquisities, Fusies, Overnames

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 jan 2026, 20:21 UTC

Marktinformatie

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 jan 2026, 19:44 UTC

Marktinformatie

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 jan 2026, 18:50 UTC

Marktinformatie

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 jan 2026, 17:48 UTC

Winsten

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 jan 2026, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

8 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

8 jan 2026, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

8 jan 2026, 16:45 UTC

Marktinformatie

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 jan 2026, 16:03 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 jan 2026, 16:03 UTC

Marktinformatie

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 jan 2026, 16:02 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 jan 2026, 15:23 UTC

Acquisities, Fusies, Overnames

Paramount Defends Its Hostile Bid for Warner -- Update

Peer Vergelijking

Prijswijziging

Mersana Therapeutics Inc Prognose

Koersdoel

By TipRanks

5.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 30.75 USD  5.74%

Hoogste 30.75 USD

Laagste 30.75 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Mersana Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

3 ratings

0

Buy

3

Hold

0

Sell

Technische score

By Trading Central

0.311 / 0.355Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

190 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

help-icon Live chat